Covella Pharmaceuticals Overview

  • Founded
  • 2007
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Covella Pharmaceuticals General Information

Description

Provider of bio-technical services. The company engages in providing VLA-1 neutralizing antibodies for the multiple inflammatory and autoimmune diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • DE
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Covella Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Covella Pharmaceuticals‘s full profile, request access.

Request a free trial

Covella Pharmaceuticals Executive Team (3)

Name Title Board Seat Contact Info
Mark Totoritis MD Co-Founder
Matthew Strobeck Ph.D Co-Founder
To view Covella Pharmaceuticals’s complete executive team members history, request access »